EFFICACY OF 1.4 PERCENT SODIUM-CITRATE IN MAINTAINING ARTERIAL CATHETER PATENCY IN PATIENTS IN A MEDICAL ICU

被引:16
作者
BRANSON, PK
MCCOY, RA
PHILLIPS, BA
CLIFTON, GD
机构
[1] UNIV KENTUCKY,COLL MED,DIV PULM & CRIT CARE MED,LEXINGTON,KY 40506
[2] UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,COLL PHARM,DEPT NURSING,DIV PHARM PRACTICE & SCI,LEXINGTON,KY 40536
关键词
D O I
10.1378/chest.103.3.882
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The primary purpose of this study was to compare the efficacy of 1.4 percent sodium citrate with heparin, 4 U/ml, for maintaining radial artery catheter patency in patients in the medical ICU. Patients and Methods: Patients in the medical ICU (n = 40) were randomized to either a 1.4 percent sodium citrate or heparin 4 U/ml arterial line flush solution in a double-blind, parallel fashion. The flush solutions were continuously infused at approximately 3 ml/h over a maximum of 96 h. Catheter survival rates were compared using Kaplan-Meier survival curves. The frequency of catheter malfunctions and corrective manipulations were recorded and compared. Coagulation status (APTT, PT) and ionized calcium values were monitored to evaluate the systemic effects of sodium citrate. Results: Ninety-four percent of catheters flushed with sodium citrate were functional at 48 h compared with 88 percent for heparin (p>0.05). At 96 h, 80 percent vs 88 percent of the catheters were functional in the citrate and heparin groups, respectively (p>0.05). Frequency of catheter malfunctions did not differ between the two groups. No systemic effects of sodium citrate were observed. Conclusion: Arterial catheter flush solutions containing sodium citrate (1.4 percent) are an effective and safe alternative to heparin in patients requiring peripheral arterial catheterization.
引用
收藏
页码:882 / 885
页数:4
相关论文
共 13 条
[2]   REGIONAL SODIUM-CITRATE ANTICOAGULATION IN PATIENTS WITH ACTIVE BLEEDING UNDERGOING HEMODIALYSIS [J].
ASHOURI, OS .
UREMIA INVESTIGATION, 1985, 9 (01) :45-51
[3]  
CLIFTON GD, 1991, HEART LUNG, V20, P115
[4]  
HERRERDA N, 1989, INT PHARM ABSTRATS, V26, P519
[5]  
Hester J P, 1983, J Clin Apher, V1, P149, DOI 10.1002/jca.2920010306
[6]  
HIRSH J, 1991, NEW ENGL J MED, V324, P1565
[7]  
HOWLAND WS, 1957, SURG GYNECOL OBSTET, V105, P523
[8]   HEPARIN-ASSOCIATED THROMBOCYTOPENIA [J].
KING, DJ ;
KELTON, JG .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (04) :535-540
[9]   CARDIAC-ARREST FOLLOWING DIRECT INTRAVENOUS ADMINISTRATION OF A CITRATE ANTICOAGULANT SOLUTION [J].
LEE, BL ;
AUERBACH, PS ;
OLSON, KR ;
OSTERLOH, JD ;
CARMONA, R .
ANNALS OF EMERGENCY MEDICINE, 1986, 15 (11) :1353-1356
[10]  
MATHEWS DE, 1988, USING UNDERSTANDING, P68